ADAM metallopeptidase with thrombospondin type 1 motif nine antisense RNA 2 (ADAMTS9-AS2) was down-regulated in ccRCC plasma in our study. Here, ADAMTS9-AS2 is linked to nonpapillary renal cell carcinoma.